Natural History of New-onset Inflammatory Bowel Disease Among Patients With Multiple Sclerosis
Gandhi, Shiv Zelman, Sara De Armas, Ricardo Eduardo Hemond, Christopher C Levy, Alexander N Singh, Siddharth Korzenik, Joshua Jangi, Sushrut
Gandhi, Shiv
Zelman, Sara
De Armas, Ricardo Eduardo
Hemond, Christopher C
Levy, Alexander N
Singh, Siddharth
Korzenik, Joshua
Jangi, Sushrut
Citations
Altmetric:
Student Authors
Faculty Advisor
Academic Program
UMass Chan Affiliations
Document Type
Journal Article
Publication Date
2022-03-26
Subject Area
Embargo Expiration Date
Link to Full Text
Abstract
Lay Summary
Patients with MS and IBD were as likely to have stricturing, fistulizing, and extensive IBD as IBD controls. Although MS-IBD patients were less likely to initiate anti-TNF therapy, they did not have worsened risk of progression to surgery on follow-up.
Source
Gandhi S, Zelman S, De Armas RE, Hemond C, Levy AN, Singh S, Korzenik J, Jangi S. Natural History of New-onset Inflammatory Bowel Disease Among Patients With Multiple Sclerosis. Inflamm Bowel Dis. 2022 Oct 3;28(10):1614-1617. doi: 10.1093/ibd/izac053. PMID: 35348692; PMCID: PMC9527605.
Year of Medical School at Time of Visit
Sponsors
Dates of Travel
DOI
10.1093/ibd/izac053
Permanent Link to this Item
PubMed ID
35348692